Study Of Lipid Profile In Cirrhotic Patients
Study Of Lipid Profile In Cirrhotic Patients
Keywords:
Cirrhosis, Dyslipidemia Lipid profileAbstract
Background &Objective: liver cirrhosis is a chronic inflammatory condition associated with lipid abnormalities. The aim is to study lipid profile in liver disease and to determine the lipid profile in patients with cirrhosis and to asses if it relates to the severity of the cirrhosis. Materials and Methods: In an analytical cross-sectional study, 40 patients with cirrhosis (case) and 40 age- and sex-matched healthy normolipidemic patients (control) were studied in Dhiraj General Hospital, Pipariya, and Vadodara. Details including personal characteristics, etiology of cirrhosis, and lipid profile (total, LDL, and HDL cholesterol and triglyceride) was taken for each patient (both case and control). Statistical analysis was done and results were documented. Results: In patients with cirrhosis, there was a significant decrease in serum total cholesterol, triglyceride, LDL and HDL cholesterol levels compared to the control group (mean of 132 vs. 186, 78 vs. 182, 76 vs. 137, and 41 vs. 47 mg/dL, respectively; all p<0.05). Interpretation & Conclusion: Serum total, LDL and HDL cholesterol level in patients with cirrhosis is inversely correlate with severity of cirrhosis.
References
metabolism: potential therapeutics for dyslipidemia, diabetes, and chronic heart and liver
diseases. Curr Opin Investing Drugs. 2005; 6:994-
1001.
2. Miller JP, Dyslipoproteinaemia of liver diseases.
Baillieres Clin Endocrinol Metab. 1990; 4: 807-32.
3. Khalid Amin, Masood Javed, Muhammad Abid,
et al: Pattern of dyslipidemia in patients with CRF.
Profes-sional Med J 2006; 13: 79-86.
4. Kasper D, Hauser S, Braunwald E, Fauci A, Lango
D. Harrison principles of internal medicine.17th
Edition. 17 ed.: McGrow-Hill 2008.
5. Andreoli T, Carpenter C, Griggs R. Cecil essential
of medicine. 7 ed.; 2007.
6. Feldman M, Friedman LS, Brandt LG. Sleisenger
& Ford Tran’s Gastrointestinal & liver Disease. 8
ed.: Elsevier Saunders; 2006.
7.Ooik, Shiraki K, Sakurai Y, Morishita Y, Nobori T. Clinical significance of abnormal lipoprotein patterns in liver diseases. Int J Mol Med. 2005; 15:655-60.
8. Joel J. Heidelbaugh, M.D., And Michael Bruderly, M.D. Cirrhosis and Chronic Liver Failure: Part I. Diagnosis and Evaluation American Family Physician September 1, 2006,Volume 74.
9. Mehboob F., Ranjha F.A., Masud S. Changes in Serum Lipid Profile among Patients Suffering From Chronic Liver Disease. Annals Vol 13. No. 3 Jul.- Sept. 2007
10. Siagris D, Christofidou M, Theocharis GJ, et al. Serum lipid pattern in chronic hepatitis C: histological and virological correlations. J Viral Hepat. 2006; 13(1):56-61.
11. Andrikoula M, Avades T. Hypolipidaemia is not
always indicating liver dysfunction. A review of primary and secondary high density lipoprotein and low density lip-oprotein deficiencies. Minerva Med. 2006; 97: 487-94.
12.Perales.Sposito AC, Vinagre CG, Pandullo FL, Mies S, Raia S, Ramires JA. Apolipoprotein and lipid abnormalities in chronic liver failure. Braz J Med Biol Res. 1997;30(11):1287-90.)
13.Taylor GO, Bamgboye AE. Serum cholesterol and diseases in Nigerians. Am J Clin Nutr 1979;32:2540-2545
14.Ojo OS, Olude IO, Odesanmi WO. The pathological basis of chronic liver disease in a tropical population A biopsy study. Orient Journal of Medicine 1990; 2:190-193.
15. Ahaneku JE,Taylor GO, Olubuyide IO, Agbedana EO. Abnormal lipid and lipoprotein patterns in liver cirrhosis with and without hepatocellular carcinoma. J Pak Med Assoc. 1992. 42:260-263
